| Document Date: 2014-07-10 09:25:59
Open Document File Size: 574,38 KBShare Result on Facebook
City Raleigh / / Company Salix Pharmaceuticals Inc. / Patheon Inc. / Napo Pharmaceuticals Inc. / / Continent South America / / Country United States / / Currency pence / / IndustryTerm drug product / food / / MedicalCondition abdominal pain / HIV / acne / disease / herpes zoster / gastroenteritis / DOSAGE FORMS AND STRENGTHS WARNINGS AND PRECAUTIONS Nasopharyngitis / celiac sprue / bronchitis / Carcinogenesis / Urinary tract infection / dermatitis / GI disease / Hemorrhoids / Nausea / Crohn’s disease / pain / ulcerative colitis / Giardiasis / infectious diarrhea / infectious etiologies / HIV/AIDS / chronic pancreatitis / diarrhea / seasonal allergy / cystic fibrosis transmembrane conductance regulator / CONTRAINDICATIONS Arthralgia / sinusitis / dizziness / cough / constipation / depression / Back pain / nephrolithiasis / respiratory tract infection / non-infectious diarrhea / upper respiratory tract infection / / MedicalTreatment anti-retroviral therapy / antiretroviral therapy / / NaturalFeature CFTR Cl¯ channel / / Organization DOSAGE AND ADMINISTRATION / FDA / Lamivudine FULYZAQ administration / Nelfinavir / Zidovudine / and Lamivudine FULYZAQ administration / / / Product Efavirenz / Zidovudine / Tenofovir disoproxil fumarate / talc / Nevirapine / Abacavir / Lamivudine / adenosine / Delayed-Release Tablets / FULYZAQ tablets / / ProvinceOrState North Carolina / / RadioStation CFTR / AM 1 / AM 3 / / Technology Pharmacokinetics / polymerization / Pharmacodynamics / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas